Up a level |
Griffiths, Gareth O, FitzGerald, Richard, Jaki, Thomas, Corkhill, Andrea, Reynolds, Helen ORCID: 0000-0001-7443-4520, Ewings, Sean, Condie, Susannah, Tilt, Emma, Johnson, Lucy, Radford, Mike et al (show 27 more authors)
(2021)
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
TRIALS, 22 (1).
487-.
Chandiwana, Nomathemba, Kruger, Chelsea, Johnstone, Hilary, Chughlay, Mohamed Farouk, Ju, Chung, Kim, Byungsu, Dineka, Yengiwe, Arbe-Barnes, Sarah, Miller, Robert, Owen, Andrew ORCID: 0000-0002-9819-7651 et al (show 6 more authors)
(2022)
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.
EBIOMEDICINE, 86.
104322-.
Venter, WD Francois, Sokhela, Simiso, Calmy, Alexandra, Mkhondwane, Luckyboy, Bosch, Bronwyn, Chandiwana, Nomathemba, Hill, Andrew, Sekwese, Kenly, Mashabane, Nkuli, Pozniak, Anton et al (show 11 more authors)
(2021)
Weight gain stopping/switch rules for antiretroviral clinical trials.
AIDS, 35 (Suppl ).
S183-S188.